Hospital Universitario Rio Hortega — Clinical Trial Site

60 Registered trials

27 Currently recruiting

Organisation

Hospital Universitario Rio Hortega

Location

Valladolid, Spain

Identifier

ORG-100039573

Address

Calle Dulzaina 2, 47012, Spain

Departments

#3412 - Medicina interna
3412: Reumatología
Anestesiología y Reanimación
Aparato Digestivo
Autoinmmune Diseases
Cirugía
Cirugía general
Dermatology
Digestive
Digestivo
Endocrinología
Endoscopia
Gastroenterology
Hematología
Hematology
Hepatology department
Hepatology Service
Hospital Rio Hortega (#1)
Intensive Medicine
Internal Medicine
Medical Doctor
Medicina interna
N/A
Neumología
Neurologia
Ophtalmology
Ophthalmology
Ophthalmology service
Pneumology
Psychiatry
Psychiatry and mental health
Psychiatry service
Pulmonology
Rheumatology
Serv. De Reumatología
Servicio de Gastroenterología y Hepatología
Servicio de Hematologica
Servicio de Medicina Interna
Surgery
Urology

Clinical trials at this site (60)

Search interface

A clinical trial to assess the safety of EXV-802 and EXV-801 and how well they work to reduce agitation symptoms in people with Alzheimer's … Pending

2024-517388-22-00 Agitation in Alzheimer's Disease Dementia 10
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending

2024-518821-13-00 Non-cystic Fibrosis Bronchiectasis 4
Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the pr… Pending

2025-521301-40-00 Prevention of new morphometric vertebral fractures and/ 6
A Study of Enpatoran in Cutaneous Manifestations of Lupus With or Without Systemic Disease. Pending

2025-524855-30-00 Cutaneous Manifestations of Lupus Erythematosus With or 5
Study on the use of high-flow oxygen to improve the safety of high-risk patients during sedated digestive endoscopies Pending

2026-525766-21-01 Hypoxemic episodes in patients undergoing gastroscopy, 6
Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Recruiting

2024-519994-20-00 Agitation Associated with Alzheimer’s Disease 5 2026-06-01
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-2) Recruiting

2022-500700-22-00 Active Systemic Lupus Erythematosus (SLE) 5 2023-05-25
Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasiv… Recruiting

2024-520006-19-00 Non-muscle invasive bladder cancer 6 2021-12-15
eValuating the efficacy and safety of InitiatinG depemokImab earLy therApy iN COPD with Type 2 inflammation (VIGILANT) Recruiting

2025-521108-23-00 Chronic Obstructive Pulmonary Disease 5 2026-05-19
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Nipocalimab in Adults with Moderate to Severe Systemic Lupus E… Recruiting

2025-523552-31-00 Systemic Lupus Erythematosus 5 2026-05-07
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated with Alzheimer’s Disease. Recruiting

2025-520613-31-00 Agitation Associated with Alzheimer’s Disease 5 2025-10-31
Inhaled sedation in the critically ill patient Recruiting

2024-518521-14-00 Critical condition 6 2025-10-17
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese and Japanese Participants, a… Recruiting

2024-514186-18-00 Systemic Lupus Erythematosus 1 2025-09-09
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants with Systemic Lupus Ery… Recruiting

2024-519015-34-00 Systemic Lupus Erythematosus 1 2025-06-30
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
A Phase 3, Parallel Group Study to Evaluate KarXT as a Treatment for Psychosis Associated with Alzheimer’s Disease Recruiting

2024-516363-92-00 Psychosis Associated with Alzheimer’s Disease 5 2025-04-08
A study describing the efficacy and safety of belimumab administered subcutaneously in adult participants with early systemic lupus erythema… Recruiting

2023-509146-35-00 Systemic Lupus Erythematosus 6 2025-01-30
ANALYSIS OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED COLON CANCER. Recruiting

2024-519825-39-00 Locally advanced colon cancer (LACC) 4 2025-01-30
Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions (DEXA-REFINE) Recruiting

2024-519759-27-00 Acute Hypoxemic Respiratory Failure 6 2024-12-20
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared … Recruiting

2023-504022-19-01 Polymyositis or dermatomyositis according to 2017 EULAR 5 2024-12-13
Long-term safety and tolerability of cenerimod in adults with systemic lupus erythematosus (OPUS OLE) Recruiting

2024-514354-67-00 Systemic lupus erythematosus 5 2024-11-01